ProCE Banner Activity

Biologic Therapies in Metastatic Colorectal Cancer: Mastering Your Moves Beyond First Line

Clinical Thought
Selecting therapies for metastatic CRC through subsequent lines of therapy can often feel like a chess match. Here’s my approach.

Released: June 10, 2016

Expiration: June 09, 2017

No longer available for credit.

Share

Faculty

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech Roche Virology

Faculty Disclosure

Primary Author

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

John L. Marshall, MD, has disclosed that he has received consulting fees, funds for research support, and funds for non-CME/CE services from Amgen, Bayer, Celgene, Genentech, and Taiho.